The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.
AstraZeneca has been denied approval by the FDA for the use of its asthma drug Symbicort in children aged 6-11 years old. ... Symbicort was approved in the US for use in children over 12 years old for long-term maintenance of asthma in July 2009.
Highly commended: Zonegran by Big Pink for Eisai Ltd. Winner: Symbicort Smart.
by Pfizer. . Highly Commended. Symbicort SMART Launch. by AstraZeneca in association
Symbicort racked up FY06 global sales of USD 1.2bn. The EU region accounted for USD 1bn of total sales. ... They also reduced estimates of Symbicort's 2012 sales in the EU region from USD 1.7bn to USD 599m.
The US Food and Drug Administration (FDA) has approved AstraZeneca's (AZ) inhaled asthma drug, Symbicort, for the long-term treatment of patients aged 12 or over - a year earlier than ... AZ plans to market Symbicort in the US in mid-2007. Shares in AZ
[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....